These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 8039599
1. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FI. Diabetes; 1994 Aug; 43(8):1046-51. PubMed ID: 8039599 [Abstract] [Full Text] [Related]
2. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function. Haraguchi K, Hara S, Ubara Y, Tanaka S, Nukui I, Shimura H, Ohashi K, Kobayashi T. Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360 [Abstract] [Full Text] [Related]
3. Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients. De Cesaris R, Ranieri G, Filitti V, Andriani A, Bonfantino MV. J Cardiovasc Pharmacol; 1993 Aug; 22(2):208-14. PubMed ID: 7692159 [Abstract] [Full Text] [Related]
4. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S. Clin Exp Hypertens; 2005 Aug; 27(2-3):129-38. PubMed ID: 15835375 [Abstract] [Full Text] [Related]
5. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy. White KE, Marshall SM, Bilous RW. Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622 [Abstract] [Full Text] [Related]
6. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects. Ahmad J, Shafique S, Abidi SM, Parwez I. Diabetes Res Clin Pract; 2003 May; 60(2):131-8. PubMed ID: 12706322 [Abstract] [Full Text] [Related]
7. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Ann Intern Med; 1993 Apr 15; 118(8):577-81. PubMed ID: 8452322 [Abstract] [Full Text] [Related]
8. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. White KE, Bilous RW. J Am Soc Nephrol; 2000 Sep 15; 11(9):1667-1673. PubMed ID: 10966491 [Abstract] [Full Text] [Related]
9. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L. Srp Arh Celok Lek; 2002 Sep 15; 130(3-4):73-80. PubMed ID: 12154518 [Abstract] [Full Text] [Related]
10. Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant? White KE, Marshall SM, Bilous RW. Diabetologia; 2007 May 15; 50(5):906-12. PubMed ID: 17333103 [Abstract] [Full Text] [Related]
11. Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria. Lee YH, Kim KP, Kim YG, Moon JY, Jung SW, Park E, Kim JS, Jeong KH, Lee TW, Ihm CG, Jo YI, Choi HY, Park HC, Lee SY, Yang DH, Yi JH, Han SW, Lee SH. Medicine (Baltimore); 2017 Sep 15; 96(36):e8047. PubMed ID: 28885376 [Abstract] [Full Text] [Related]
12. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS. Kidney Int; 2000 Feb 15; 57(2):590-600. PubMed ID: 10652036 [Abstract] [Full Text] [Related]
13. Aggressive antihypertensive treatment and serum lipid lowering therapy are necessary to prevent deterioration of the renal function even in elderly type 2 diabetic patients with persistent albuminuria. Narita T, Kakei M, Ito S. Gerontology; 2002 Feb 15; 48(5):302-8. PubMed ID: 12169796 [Abstract] [Full Text] [Related]
14. Structural involvement in type 1 and type 2 diabetic nephropathy. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P. Diabetes Metab; 2000 Jul 15; 26 Suppl 4():8-14. PubMed ID: 10922968 [Abstract] [Full Text] [Related]
15. The effect of the non-ionic contrast medium iohexol on glomerular and tubular function in diabetic patients. Apelqvist J, Torffvit O, Agardh CD. Diabet Med; 1996 May 15; 13(5):487-92. PubMed ID: 8737033 [Abstract] [Full Text] [Related]
16. Clinical and histological correlation of diabetic nephropathy. Afroz T, Sagar R, Reddy S, Gandhe S, Rajaram KG. Saudi J Kidney Dis Transpl; 2017 May 15; 28(4):836-841. PubMed ID: 28748886 [Abstract] [Full Text] [Related]
17. Glomerular filtration surface in type I diabetes mellitus. Ellis EN, Steffes MW, Goetz FC, Sutherland DE, Mauer SM. Kidney Int; 1986 Apr 15; 29(4):889-94. PubMed ID: 3712971 [Abstract] [Full Text] [Related]
18. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients. Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P. Eur J Med; 1992 Sep 15; 1(5):268-72. PubMed ID: 1341608 [Abstract] [Full Text] [Related]
19. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D. Presse Med; 2002 Nov 09; 31(36):1714-20. PubMed ID: 12467154 [Abstract] [Full Text] [Related]
20. Kidney involvement in a nongenetic rat model of type 2 diabetes. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. Kidney Int; 2005 Dec 09; 68(6):2562-71. PubMed ID: 16316331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]